The earnings call highlighted new leadership and significant contract wins, but these were overshadowed by disappointing bioprocessing performance, adjusted margin declines, and reduced guidance due to various operational and market challenges.
Company Guidance
During Avantor's Second Quarter 2025 Earnings Results Conference Call, the company provided several key metrics about its performance and future guidance. Organic revenue growth was flat year-over-year but improved sequentially by 200 basis points. The adjusted EBITDA margin for the quarter contracted to 16.6%, and adjusted earnings per share (EPS) was reported at $0.24. Free cash flow for the quarter stood at $125 million, with an adjusted conversion rate of 100%. The company also highlighted its ongoing cost transformation program, expecting $400 million in run-rate savings by the end of 2027. In the Lab Solutions segment, organic revenue growth was down slightly year-over-year but increased sequentially. Significant contract wins in the lab business were noted, which are expected to yield over $100 million in share gains. However, challenges were noted in the Bioscience Production segment due to unexpected customer headwinds and extended maintenance at a manufacturing facility. As a result, Avantor updated its full-year guidance, now expecting organic revenue growth to range from negative 2% to flat, with adjusted EBITDA margins between 16.5% and 17%.
Leadership Transition
Emmanuel Ligner has been appointed as the next CEO of Avantor, effective August 18, bringing over 30 years of experience in the life sciences industry.
Contract Extensions and Market Share Gains
Avantor secured contract extensions with several top 15 global pharma accounts, resulting in more than $100 million in share gains. The company also executed a 5-year extension of its contract with BIO Business Solutions.
NuSil Platform Growth
Strong performance in the NuSil-branded silicones platform, which grew low double digits year-to-date.
Avantor (AVTR) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AVTR Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 01, 2025
$13.44
$11.36
-15.48%
Apr 25, 2025
$15.50
$12.93
-16.58%
Feb 07, 2025
$21.70
$19.16
-11.71%
Oct 25, 2024
$23.27
$22.43
-3.61%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Avantor Inc (AVTR) report earnings?
Avantor Inc (AVTR) is schdueled to report earning on Oct 24, 2025, Before Open (Confirmed).
What is Avantor Inc (AVTR) earnings time?
Avantor Inc (AVTR) earnings time is at Oct 24, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.